Nicotine delivery and user reactions to Juul EU (20 mg/ml) compared with Juul US (59 mg/ml), cigarettes and other e-cigarette products.


Journal

Psychopharmacology
ISSN: 1432-2072
Titre abrégé: Psychopharmacology (Berl)
Pays: Germany
ID NLM: 7608025

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 14 07 2020
accepted: 23 11 2020
pubmed: 4 12 2020
medline: 16 3 2021
entrez: 3 12 2020
Statut: ppublish

Résumé

The degree to which the EU version of Juul with 20 mg/ml nicotine (Juul EU) delivers nicotine to users is likely to determine its treatment potential. To compare the pharmacokinetic profile and user ratings of Juul EU, Juul US (59 mg/ml nicotine), cigarettes and other e-cigarette (EC) products. In a within-subjects crossover design, 18 vapers used, at separate sessions, their own brand cigarette (OBC), Juul US and Juul EU for 5 min ad libitum, after overnight abstinence. Seven of the participants also tested eight other EC previously. Blood samples were taken at baseline and 2, 4, 6, 8, 10 and 30 min after initiating product use. Products were rated on a range of characteristics. Juul EU delivered less nicotine than OBC (t(13) = -4.64 p < .001) and than Juul US (t(13) = -6.40, p < .001): AUC Juul EU delivers much less nicotine to users than Juul US, and also less than refillable EC products. It may thus have more limited potential to help smokers quit.

Identifiants

pubmed: 33270145
doi: 10.1007/s00213-020-05734-2
pii: 10.1007/s00213-020-05734-2
pmc: PMC7914237
doi:

Substances chimiques

Nicotine 6M3C89ZY6R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

825-831

Subventions

Organisme : Cancer Research UK
ID : C49913/A25756
Pays : United Kingdom

Références

Tob Control. 2019 Jan;28(1):110-112
pubmed: 29654121
JAMA. 2018 Oct 2;320(13):1379-1380
pubmed: 30285167
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Feb 1;879(3-4):267-76
pubmed: 21208832
Psychopharmacology (Berl). 2017 Mar;234(5):773-779
pubmed: 28070620
Addict Behav. 2019 Apr;91:102-105
pubmed: 30054021
Addiction. 2020 Jun;115(6):1141-1148
pubmed: 31994254
Psychopharmacology (Berl). 2018 Apr;235(4):1083-1092
pubmed: 29306962
Comput Methods Programs Biomed. 2010 Sep;99(3):306-14
pubmed: 20176408
Sci Rep. 2020 Apr 30;10(1):7322
pubmed: 32355323

Auteurs

Anna Phillips-Waller (A)

Health and Lifestyle Research Unit, Queen Mary University of London, 2 Stayner's Road, London, E14AH, UK. a.phillips-waller@qmul.ac.uk.

Dunja Przulj (D)

Health and Lifestyle Research Unit, Queen Mary University of London, 2 Stayner's Road, London, E14AH, UK.

Katie Myers Smith (KM)

Health and Lifestyle Research Unit, Queen Mary University of London, 2 Stayner's Road, London, E14AH, UK.

Francesca Pesola (F)

Health and Lifestyle Research Unit, Queen Mary University of London, 2 Stayner's Road, London, E14AH, UK.

Peter Hajek (P)

Health and Lifestyle Research Unit, Queen Mary University of London, 2 Stayner's Road, London, E14AH, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH